Send Inquiry

Request To Call Back

Zydus Saroglitazar Tablets Bilypsa

Name: Zydus Saroglitazar Tablets Bilypsa
Brand: ONCOTRUST
Price: 1400.0 INR
Availability: InStock

Price 1400.0 INR/ Piece

Get a Price/Quote

MOQ : 100 Pieces

Zydus Saroglitazar Tablets Bilypsa Specification

Salt Composition
Saroglitazar 4 mg

Dosage Form
Tablet

Indication
Dyslipidemia, Hypertriglyceridemia, Type 2 Diabetes Mellitus, Non-alcoholic Fatty Liver Disease (NAFLD)

Feature
Dual PPAR alpha/gamma agonist for comprehensive lipid and glycemic control

Ingredients
Saroglitazar

Application
Oral Administration for lipid and glycemic control

Temperature Needed For Fermentation
28 Celsius (oC)

Physical Color/Texture
White to off-white tablets

Fermentation Smell
Odorless

Storage Instructions
Store below 30C, protect from moisture and light

Shelf Life
24 Hours

Marketing Authorization Holder
Zydus Healthcare Ltd.

Pack Size
10 tablets per strip

Administration Route
Oral

Brand Name
Bilypsa

Storage Condition
Keep in a cool, dry place

Manufactured By
Zydus Healthcare Ltd.

Approval Status
CDSCO approved

Product Code
Bilypsa

Therapeutic Class
Antihyperlipidemic and Antidiabetic

Prescription/OTC Status
Prescription only

About Zydus Saroglitazar Tablets Bilypsa

Bilypsa Tablets contain Saroglitazar, a novel dual PPAR- and PPAR- agonist, widely prescribed for the management of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) associated with metabolic disorders. It helps improve liver health by reducing triglycerides, improving insulin sensitivity, and lowering liver enzyme levels.

Bilypsa is also effective in managing diabetic dyslipidemia, making it a preferred choice among physicians for patients with type 2 diabetes and abnormal lipid profiles.

Key Benefits

Helps in management of NAFLD / NASH
Reduces triglycerides and liver fat
Improves insulin sensitivity
Lowers ALT and AST liver enzymes
Supports overall metabolic and liver health

Indications

Non-Alcoholic Fatty Liver Disease (NAFLD)
Non-Alcoholic Steatohepatitis (NASH)
Diabetic Dyslipidemia
Type 2 Diabetes with lipid abnormalities

Dosage & Administration

As directed by the physician. Usually taken once daily.

Packaging

Strip / Box packing (as per availability)

Storage

Store in a cool, dry place. Protect from moisture and direct sunlight

Dual Action Management for Lipids and Sugar

Bilypsa offers a unique therapeutic benefit by acting as both an antihyperlipidemic and antidiabetic agent. This dual-action effect makes it particularly effective for individuals struggling with both high cholesterol and elevated blood sugar levels, providing holistic metabolic control.

Advanced Formulation for Enhanced Patient Outcomes

Formulated with Saroglitazar, Bilypsa utilizes dual PPAR alpha/gamma agonist activity, addressing the root causes of metabolic disorders. This targeted mechanism ensures both lipid and glycemic regulation, demonstrating efficacy and safety for long-term use as validated by CDSCO approval.

Practical Dosage and Easy Storage

Bilypsa tablets are intended for oral administration and are supplied in convenient strips of 10. The tablets are easy to store-simply keep them in a cool, dry place, away from direct light and moisture, at temperatures below 30C, preserving their effectiveness throughout their 24-month shelf life.

FAQ's of Zydus Saroglitazar Tablets Bilypsa:

Q: How should Bilypsa tablets be taken?

A: Bilypsa tablets are taken orally, usually once daily as directed by your physician. Follow your healthcare provider's prescription for optimal lipid and glycemic control, and do not alter your dosage without consultation.

Q: What is the primary benefit of using Bilypsa?

A: Bilypsa provides dual regulation of both lipids and blood glucose, making it ideal for individuals who need comprehensive management of dyslipidemia, hypertriglyceridemia, type 2 diabetes mellitus, or NAFLD.

Q: When should I take Bilypsa?

A: It is generally recommended to take Bilypsa at the same time each day, as prescribed by your healthcare provider, to maintain consistent blood levels of the medication.

Q: Where should Bilypsa tablets be stored?

A: Store Bilypsa tablets in a cool, dry place below 30C, protecting them from moisture and direct sunlight to ensure their potency for up to 24 months.

Q: What process does Bilypsa use for metabolic control?

A: Bilypsa acts as a dual PPAR alpha/gamma agonist, targeting both lipid and glucose metabolic pathways for comprehensive disease management.

Q: Is a prescription necessary to obtain Bilypsa?

A: Yes, Bilypsa is available only by prescription, and it should be used under medical supervision due to its targeted therapeutic action and potential interactions.

Q: What are the approved indications for Bilypsa?

A: Bilypsa is CDSCO-approved for the treatment of dyslipidemia, hypertriglyceridemia, type 2 diabetes mellitus, and non-alcoholic fatty liver disease (NAFLD).

Tell us about your requirement